Daniel B. Soland, Director of Acadia Pharmaceuticals ACAD, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/05/29.

DS

DS

Daniel B. Soland

Director

Company

Acadia Pharmaceuticals ACAD

First filing

23/06/05

Trades

17 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/05/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
DBV TechnologiesDBVT	Open-market buy	23/08/01	23/08/03	15,000 sh	$1.62	$24,300	+300.0%